University of Minnesota Masonic Cancer Center — Minneapolis, Minnesota

University of Minnesota Masonic Cancer Center is a clinical research site located in Minneapolis, Minnesota, United States 55455.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Minnesota Masonic Cancer Center has participated in 43 clinical trials with 10 currently active.

Therapeutic areas: Hematologic Malignancies, Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL).

Sponsors: Masonic Cancer Center, University of Minnesota, Adcentrx Therapeutics, Fate Therapeutics.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Minnesota Masonic Cancer Center?

University of Minnesota Masonic Cancer Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Minnesota Masonic Cancer Center conducted?

University of Minnesota Masonic Cancer Center has 43 clinical trials on record, with 10 currently active. Their work covers Hematologic Malignancies, Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL).

Is University of Minnesota Masonic Cancer Center accredited by Crixeo Health?

Yes — University of Minnesota Masonic Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Minnesota Masonic Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.